Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices | Market Insights | US | 2025

The landscape of the US cardiac rhythm management device market is poised for dynamic change through 2033, with trends varying by device segment. The increasing adoption of innovative devices such as leadless pacemakers is driving market growth, with these devices gaining traction as the new standard of care. In particular, the entry of the Aveir DR leadless dual-chamber pacemaker has significantly expanded the population eligible for treatment with a pacemaker.

This Medtech 360 Report provides comprehensive data and analysis on the state of the US cardiac rhythm management device market from 2019 through 2033.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe (Supplemental)
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period, driven primarily by rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and…
Report
Cardiac Rhythm Management Devices | Market Insights | Europe | 2024
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs…